文献速递脊柱关节炎

血清炎症生物标志物无法识别早期中轴型脊柱关节炎:SPACE队列结果

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.
PubMed 文献 · RMD Open · 2017-01-11

该研究在SPACE早期背痛起始队列(n=310)中评估血清CRP、ESR和钙卫蛋白区分早期中轴型脊柱关节炎(axSpA)与其他背痛病因的价值,并在强直性脊柱炎(AS)患者(n=21)与健康对照(n=20)中探索IL-27、hBD-2和LCN-2。结果显示CRP和ESR在早期axSpA中未升高,钙卫蛋白虽升高但个体识别能力不足(阳性预测值38.7%),探索性标志物亦无升高。结论认为候选血清炎症标志物均不能作为早期axSpA的诊断标志物。

要点

  • 早期axSpA患者血清CRP和ESR水平较对照背痛患者未升高。
  • 血清钙卫蛋白在早期axSpA中升高(p=0.01),但阳性预测值仅38.7%。
  • IL-27不可检测,hBD-2和LCN-2在AS与健康对照间无差异(p=0.572、p=0.562)。

核心结论

  • 候选血清炎症标志物均不能作为早期axSpA的诊断标志物。

研究设计与样本

  • SPACE早期背痛起始队列纳入310例患者,检测血清CRP、ESR和钙卫蛋白。
  • 探索性标志物IL-27、hBD-2和LCN-2在21例AS患者和20例健康对照中通过ELISA检测。

主要发现

  • 早期axSpA患者血清CRP和ESR水平较对照背痛患者未升高。
  • 早期axSpA患者血清钙卫蛋白较对照升高(p=0.01),但个体识别阳性预测值为38.7%。
  • AS患者血清hBD-2和LCN-2较健康对照未升高(p=0.572和p=0.562),IL-27血清水平不可检测。

关键数值与推荐

  • 钙卫蛋白区分早期axSpA的阳性预测值为38.7%。
  • hBD-2在AS与健康对照间比较p=0.572;LCN-2比较p=0.562。

临床怎么用

  • 血清CRP、ESR和钙卫蛋白不宜用于早期axSpA的个体化诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Decreasing the diagnostic delay in axial spondyloarthritis (axSpA) remains a major challenge. Here, we assessed the value of serum inflammatory biomarkers to distinguish early axSpA from other pathologies in a large cohort of patients referred with early back pain. METHODS: Serum c reactive protein (CRP), erythrocyte sedimentation rate (ESR) and calprotectin were determined in the SPondyloArthritis Caught Early (SPACE) cohort (n=310), an early back pain inception cohort. Additionally, explorative serum biomarkers derived from the literature (interleukin-27 (IL-27), human β-defensin-2 (hBD-2) and lipcolin-2 (LCN-2)) were determined by ELISA in full-blown patients with ankylosing spondylitis (AS) (n=21) and healthy controls (n=20). RESULTS: Serum CRP and ESR levels were not elevated in early axSpA versus 'control' back pain patients. Serum calprotectin was elevated in early axSpA versus controls (p=0.01) but failed to identify early axSpA at the individual level (positive predictive value of 38.7%). As to explorative biomarkers, serum levels of IL-27 were not detectable, and hBD-2 and LCN-2 serum levels were not elevated in full-blown AS versus healthy controls (p=0.572, p=0.562, respectively). Therefore, these markers were not further determined in the SPACE cohort. CONCLUSIONS: None of the candidate serum inflammatory markers were useful as diagnostic markers in the early phase of axSpA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Turina MC, Yeremenko N, van Gaalen F, et al. Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open. 2017. PMID: 28123777. doi:10.1136/rmdopen-2016-000319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。